A pediatric neurologic assessment score may drive the eculizumab-based treatment of Escherichia coli-related hemolytic uremic syndrome with neurological involvement.
Giordano P, Netti GS, Santangelo L, Castellano G, Carbone V, Torres DD, Martino M, Sesta M, Di Cuonzo F, Resta MC, Gaeta A, Milella L, Chironna M, Germinario C, Scavia G, Gesualdo L, Giordano M.
Giordano P, et al. Among authors: di cuonzo f.
Pediatr Nephrol. 2019 Mar;34(3):517-527. doi: 10.1007/s00467-018-4112-2. Epub 2018 Oct 25.
Pediatr Nephrol. 2019.
PMID: 30362078